Factory Mutual Insurance Company Holds Holding in Merck & Co INC (MRK)

Merck & Co., Inc. (NYSE:MRK) LogoInvestors sentiment decreased to 0.81 in Q1 2019. Its down 0.11, from 0.92 in 2018Q4. It dropped, as 50 investors sold MRK shares while 702 reduced holdings. 141 funds opened positions while 468 raised stakes. 1.86 billion shares or 4.24% less from 1.94 billion shares in 2018Q4 were reported. Jmg Fin Ltd reported 4,518 shares. Pacific Glob Investment invested in 20,613 shares. Moreover, Hutchinson Capital Mngmt Ca has 4.6% invested in Merck & Co., Inc. (NYSE:MRK) for 183,597 shares. Motco stated it has 65,518 shares. Accuvest Glob Advsrs has invested 0.26% in Merck & Co., Inc. (NYSE:MRK). Systematic Lp holds 0.13% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 43,933 shares. Cliftonlarsonallen Wealth Ltd stated it has 0.17% in Merck & Co., Inc. (NYSE:MRK). Ajo Lp holds 4.62M shares. 353,750 were reported by Pinebridge Invests Ltd Partnership. Sumitomo Mitsui Asset Mgmt invested in 248,614 shares or 0.34% of the stock. Wedge Capital Management L Limited Partnership Nc reported 3,737 shares stake. Lincoln stated it has 29,932 shares or 0.1% of all its holdings. Exchange Cap reported 46,955 shares stake. The Netherlands-based Ing Groep Nv has invested 0.2% in Merck & Co., Inc. (NYSE:MRK). Conning stated it has 615,906 shares or 1.6% of all its holdings.

Factory Mutual Insurance Company increased its stake in Merck & Co Inc (MRK) by 50.86% based on its latest 2019Q1 regulatory filing with the SEC. Factory Mutual Insurance Company bought 430,500 shares as the company’s stock declined 1.86% while stock markets rallied. The institutional investor held 1.28M shares of the health care company at the end of 2019Q1, valued at $104.06M, up from 846,436 at the end of the previous reported quarter. Factory Mutual Insurance Company who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $208.45B market cap company. The stock decreased 4.50% or $3.82 during the last trading session, reaching $81. About 20.66M shares traded or 84.13% up from the average. Merck & Co., Inc. (NYSE:MRK) has risen 29.94% since July 12, 2018 and is uptrending. It has outperformed by 25.51% the S&P500.

Factory Mutual Insurance Company, which manages about $8.47 billion US Long portfolio, decreased its stake in Boeing Co (NYSE:BA) by 75,400 shares to 146,000 shares, valued at $57.31 million in 2019Q1, according to the filing. It also reduced its holding in Facebook Inc (NASDAQ:FB) by 209,700 shares in the quarter, leaving it with 1.06M shares, and cut its stake in Jpmorgan Chase & Co (NYSE:JPM).

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Streetinsider.com which released: “AstraZeneca (AZN), Merck (MRK) Announce EC Approval of Lynparza for Ovarian Cancer – StreetInsider.com” on June 18, 2019, also Seekingalpha.com with their article: “Merck: Don’t Miss It – Seeking Alpha” published on June 28, 2019, Seekingalpha.com published: “FDA accepts supplemental BLAs from Merck to update dosing frequency for Keytruda – Seeking Alpha” on July 09, 2019. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Businesswire.com and their article: “Merck Highlights Commitment to HIV Research with Presentations for Investigational Anti-HIV Agent MK-8591 at IAS 2019 – Business Wire” published on July 10, 2019 as well as Streetinsider.com‘s news article titled: “S&P 500 near flat as healthcare in spotlight – StreetInsider.com” with publication date: July 11, 2019.

Merck & Co., Inc. (NYSE:MRK) Ratings Coverage

Among 6 analysts covering Merck \u0026 Co (NYSE:MRK), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Merck \u0026 Co had 19 analyst reports since January 23, 2019 according to SRatingsIntel. The company was maintained on Monday, March 4 by Cantor Fitzgerald. The company was maintained on Wednesday, February 20 by Argus Research. The firm earned “Buy” rating on Friday, June 21 by Bank of America. As per Friday, March 22, the company rating was maintained by Cantor Fitzgerald. The company was initiated on Thursday, February 21 by Cantor Fitzgerald. BMO Capital Markets downgraded the shares of MRK in report on Wednesday, January 23 to “Market Perform” rating. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Monday, February 25 by UBS. The rating was maintained by BMO Capital Markets on Friday, March 1 with “Hold”. The firm earned “Buy” rating on Friday, June 21 by Morgan Stanley. Cantor Fitzgerald initiated the shares of MRK in report on Tuesday, March 12 with “Buy” rating.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.